Clinical Potential of Circulating Cell-Free DNA (cfDNA) for Longitudinally Monitoring Clinical Outcomes in the First-Line Setting of Non-Small-Cell Lung Cancer (NSCLC): A Real-World Prospective Study

Overview of attention for article published in Cancers, December 2022

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (70th percentile)
Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

twitter: 6 X users

Readers on

mendeley: 20 Mendeley

So far, Altmetric has seen 8 X posts from 6 X users, with an upper bound of 9,667 followers.

RT @Cancers_MDPI: 🧐Check out #Article "Clinical Potential of Circulating Cell-Free DNA (cfDNA) for Longitudinally Monitoring Clinical Outco…

🧐Check out #Article "Clinical Potential of Circulating Cell-Free DNA (cfDNA) for Longitudinally Monitoring Clinical Outcomes in the First-Line Setting of Non-Small-Cell Lung Cancer (NSCLC): A Real-World Prospective Study" 👏by @VGristina et al 📌Link her…

RT @VGristina: #cfDNA clearance still playing a role in the longitudinal monitoring of #NSCLC on IO or TKI when compared to CT alone @isliq…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 4 additional X posts.